1. Home
  2. MLAB vs HUMA Comparison

MLAB vs HUMA Comparison

Compare MLAB & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLAB
  • HUMA
  • Stock Information
  • Founded
  • MLAB 1982
  • HUMA 2004
  • Country
  • MLAB United States
  • HUMA United States
  • Employees
  • MLAB N/A
  • HUMA N/A
  • Industry
  • MLAB Industrial Machinery/Components
  • HUMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • MLAB Industrials
  • HUMA Health Care
  • Exchange
  • MLAB Nasdaq
  • HUMA Nasdaq
  • Market Cap
  • MLAB 602.2M
  • HUMA 691.8M
  • IPO Year
  • MLAB N/A
  • HUMA N/A
  • Fundamental
  • Price
  • MLAB $102.44
  • HUMA $4.84
  • Analyst Decision
  • MLAB Hold
  • HUMA Strong Buy
  • Analyst Count
  • MLAB 2
  • HUMA 7
  • Target Price
  • MLAB $140.00
  • HUMA $12.71
  • AVG Volume (30 Days)
  • MLAB 39.1K
  • HUMA 3.2M
  • Earning Date
  • MLAB 11-07-2024
  • HUMA 11-08-2024
  • Dividend Yield
  • MLAB 0.62%
  • HUMA N/A
  • EPS Growth
  • MLAB N/A
  • HUMA N/A
  • EPS
  • MLAB N/A
  • HUMA N/A
  • Revenue
  • MLAB $228,380,000.00
  • HUMA N/A
  • Revenue This Year
  • MLAB $11.26
  • HUMA N/A
  • Revenue Next Year
  • MLAB $5.27
  • HUMA $5,405.72
  • P/E Ratio
  • MLAB N/A
  • HUMA N/A
  • Revenue Growth
  • MLAB 6.88
  • HUMA N/A
  • 52 Week Low
  • MLAB $83.68
  • HUMA $2.43
  • 52 Week High
  • MLAB $141.17
  • HUMA $9.97
  • Technical
  • Relative Strength Index (RSI)
  • MLAB 34.03
  • HUMA 40.76
  • Support Level
  • MLAB $113.26
  • HUMA $4.75
  • Resistance Level
  • MLAB $121.00
  • HUMA $6.11
  • Average True Range (ATR)
  • MLAB 5.99
  • HUMA 0.40
  • MACD
  • MLAB -1.65
  • HUMA -0.04
  • Stochastic Oscillator
  • MLAB 1.03
  • HUMA 6.25

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.

Share on Social Networks: